Suzuki H.; Kumar S.A.; Shuai S.; Diaz-Navarro A.; Gutierrez-Fernandez A.; De Antonellis P.; Cavalli F.M.G.; Juraschka K.; Farooq H.; Shibahara I.; Vladoiu M.C.; Zhang J.; Abeysundara N.; Przelicki D.; Skowron P.; Gauer N.; Luu B.; Daniels C.; Wu X.; Forget A.; Momin A.; Wang J.; Dong W.; Kim S.-K.; Grajkowska W.A.; Jouvet A.; Fevre-Montange M.; Garre M.L.; Nageswara Rao A.A.; Giannini C.; Kros J.M.; French P.J.; Jabado N.; Ng H.-K.; Poon W.S.; Eberhart C.G.; Pollack I.F.; Olson J.M.; Weiss W.A.; Kumabe T.; Lopez-Aguilar E.; Lach B.; Massimino M.; Van Meir E.G.; Rubin J.B.; Vibhakar R.; Chambless L.B.; Kijima N.; Klekner A.; Bognar L.; Chan J.A.; Faria C.C.; Ragoussis J.; Pfister S.M.; Goldenberg A.; Wechsler-Reya R.J.; Bailey S.D.; Garzia L.; Morrissy A.S.; Marra M.A.; Huang X.; Malkin D.; Ayrault O.; Ramaswamy V.; Puente X.S.; Calarco J.A.; Stein L.; Taylor M.D., Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma, «NATURE», 2019, 574, pp. 707 - 711 [articolo]
Brown, R. D.; Muratore, F.; Christianson, T. J. H.; Galli, E.; Pipitone, N.; Cassone, G.; Iii, J. H.; Giannini, C.; Warrington, K.; Hunder, G. G.; Salvarani, Carlo, Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature, «AUTOIMMUNITY REVIEWS», 2019, 18, pp. 399 - 405 [articolo]
Swanson A.A.; Raghunathan A.; Jenkins R.B.; Messing-Junger M.; Pietsch T.; Clarke M.J.; Kaufmann T.J.; Giannini C., Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2019, 78, pp. 791 - 797 [articolo]
Rodriguez F.J.; Graham M.K.; Brosnan-Cashman J.A.; Barber J.R.; Davis C.; Vizcaino M.A.; Palsgrove D.N.; Giannini C.; Pekmezci M.; Dahiya S.; Gokden M.; Noe M.; Wood L.D.; Pratilas C.A.; Morris C.D.; Belzberg A.; Blakeley J.; Heaphy C.M., Telomere alterations in neurofibromatosis type 1-associated solid tumors, «ACTA NEUROPATHOLOGICA COMMUNICATIONS», 2019, 7, pp. 139 - 150 [articolo]Open Access
Fritchie K.; Jensch K.; Moskalev E.A.; Caron A.; Jenkins S.; Link M.; Brown P.D.; Rodriguez F.J.; Guajardo A.; Brat D.; Velazquez Vega J.E.; Perry A.; Wu A.; Raleigh D.R.; Santagata S.; Louis D.N.; Brastianos P.K.; Kaplan A.; Alexander B.M.; Rossi S.; Ferrarese F.; Haller F.; Giannini C., The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma, «ACTA NEUROPATHOLOGICA», 2019, 137, pp. 307 - 319 [articolo]
Horbinski C.; Ligon K.L.; Brastianos P.; Huse J.T.; Venere M.; Chang S.; Buckner J.; Cloughesy T.; Jenkins R.B.; Giannini C.; Nabors L.B.; Wen P.Y.; Aldape K.J.; Lukas R.V.; Galanis E.; Eberhart C.G.; Brat D.J.; Sarkaria J.N., The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients, «NEURO-ONCOLOGY», 2019, 21, pp. 1498 - 1508 [articolo]
Eckel-Passow J.E.; Decker P.A.; Kosel M.L.; Kollmeyer T.M.; Molinaro A.M.; Rice T.; Caron A.A.; Drucker K.L.; Praska C.E.; Pekmezci M.; Hansen H.M.; Mccoy L.S.; Bracci P.M.; Erickson B.J.; Lucchinetti C.F.; Wiemels J.L.; Wiencke J.K.; Bondy M.L.; Melin B.; Burns T.C.; Giannini C.; Lachance D.H.; Wrensch M.R.; Jenkins R.B., Using germline variants to estimate glioma and subtype risks, «NEURO-ONCOLOGY», 2019, 21, pp. 451 - 461 [articolo]
Asioli, S; Righi, A; Iommi, M; Baldovini, C; Ambrosi, F; Guaraldi, F; Zoli, M; Mazzatenta, D; Faustini-Fustini, M; Rucci, P; Giannini, C; Foschini, M P, Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre, «EUROPEAN JOURNAL OF ENDOCRINOLOGY», 2019, 180, pp. 127 - 134 [articolo]
Chen X.; Zhang M.; Gan H.; Wang H.; Lee J.-H.; Fang D.; Kitange G.J.; He L.; Hu Z.; Parney I.F.; Meyer F.B.; Giannini C.; Sarkaria J.N.; Zhang Z., A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma, «NATURE COMMUNICATIONS», 2018, 9, Article number: 2949, pp. 1 - 14 [articolo]Open Access
Rossi S.; Brenca M.; Zanatta L.; Trincia E.; Guerriero A.; Pizzato C.; Fiorindi A.; Viscardi E.; Giangaspero F.; Maestro R.; Dei Tos A.P.; Giannini C., A pediatric intra-axial malignant smarcb1-deficient desmo-plastic tumor arising in meningioangiomatosis, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2018, 77, pp. 883 - 889 [articolo]
Koehler, J. W.; Miller, A. D.; Miller, C. R.; Porter, B.; Aldape, K.; Beck, J.; Brat, D.; Cornax, I.; Corps, K.; Frank, C.; Giannini, C.; Horbinski, C.; Huse, J. T.; O'Sullivan, M. G.; Rissi, D. R.; Simpson, R. M.; Woolard, K.; Shih, J. H.; Mazcko, C.; Gilbert, M. R.; Leblanc, A. K., A revised diagnostic classification of canine glioma: Towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2018, 77, pp. 1039 - 1054 [articolo]
Reinhardt A.; Stichel D.; Schrimpf D.; Sahm F.; Korshunov A.; Reuss D.E.; Koelsche C.; Huang K.; Wefers A.K.; Hovestadt V.; Sill M.; Gramatzki D.; Felsberg J.; Reifenberger G.; Koch A.; Thomale U.-W.; Becker A.; Hans V.H.; Prinz M.; Staszewski O.; Acker T.; Dohmen H.; Hartmann C.; Mueller W.; Tuffaha M.S.A.; Paulus W.; Hess K.; Brokinkel B.; Schittenhelm J.; Monoranu C.-M.; Kessler A.F.; Loehr M.; Buslei R.; Deckert M.; Mawrin C.; Kohlhof P.; Hewer E.; Olar A.; Rodriguez F.J.; Giannini C.; NageswaraRao A.A.; Tabori U.; Nunes N.M.; Weller M.; Pohl U.; Jaunmuktane Z.; Brandner S.; Unterberg A.; Hanggi D.; Platten M.; Pfister S.M.; Wick W.; Herold-Mende C.; Jones D.T.W.; von Deimling A.; Capper D., Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations, «ACTA NEUROPATHOLOGICA», 2018, 136, pp. 273 - 291 [articolo]
Louis D.N.; Wesseling P.; Paulus W.; Giannini C.; Batchelor T.T.; Cairncross J.G.; Capper D.; Figarella-Branger D.; Lopes M.B.; Wick W.; van den Bent M., cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC), «ACTA NEUROPATHOLOGICA», 2018, 135, pp. 481 - 484 [articolo]
Louis D.N.; Giannini C.; Capper D.; Paulus W.; Figarella-Branger D.; Lopes M.B.; Batchelor T.T.; Cairncross J.G.; van den Bent M.; Wick W.; Wesseling P., cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant, «ACTA NEUROPATHOLOGICA», 2018, 135, pp. 639 - 642 [articolo]
Pratt D.; Natarajan S.K.; Banda A.; Giannini C.; Vats P.; Koschmann C.; Mody R.; Chinnaiyan A.; Venneti S., Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas, «ACTA NEUROPATHOLOGICA», 2018, 135, pp. 299 - 301 [articolo]
